SCHEMBL6446487

SCHEMBL6446487

O=C(CCl)N1CCN(c2ccc(-c3nocc3CNc3ccon3)cc2F)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.36
ALDH1A1 P00352 6/20 0.35
MAPT P10636 5/20 0.35
LMNA P02545 2/20 0.35
KMT2A Q03164 2/20 0.35
GRM5 P41594 3/20 0.35
CKS1B P61024 1/20 0.34
SKP1 P63208 1/20 0.34
SKP2 Q13309 1/20 0.34
SMN1; SMN2 Q16637 4/20 0.34
DPP4 P27487 1/20 0.34
DPP9 Q86TI2 1/20 0.34
POLB P06746 3/20 0.33
PHGDH O43175 2/20 0.33
HPGD P15428 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4682699 0.83 GAA (0.38) GAAALDH1A1MAPTLMNAKMT2A
SCHEMBL6446483 0.78 DPP4 (0.37) GAAALDH1A1MAPTLMNAKMT2A
SCHEMBL6401628 0.73 GAA (0.40) GAAALDH1A1MAPTLMNAKMT2A
SCHEMBL6400852 0.72 SCN1A (0.34) GAASMN1; SMN2SCN1ASCN5ASCN8A
SCHEMBL1383599 0.71 GFER (0.38) GAAALDH1A1MAPTLMNAKMT2A
SCHEMBL4784687 0.70 SMN1; SMN2 (0.45) GAAALDH1A1MAPTLMNAKMT2A
SCHEMBL4684254 0.69 ALDH1A1 (0.40) GAAALDH1A1MAPTLMNAKMT2A
SCHEMBL1199475 0.69 KMT2A (0.47) GAAALDH1A1MAPTLMNAKMT2A
SCHEMBL5655207 0.67 MIF (0.45) ALDH1A1MAPTKMT2ASMN1; SMN2HPGD
SCHEMBL946774 0.67 GRM5 (0.61) ALDH1A1MAPTLMNAKMT2AGRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014806-A1 Substituted isoxazoles and their use as antibiotics LABORATORIOS S.A.L.V.A.T., S.A. (ES) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014806-A1 Substituted isoxazoles and their use as antibiotics XDH, SCO2, HAX1 GAA 4055/4885ALDH1A1 1181/4885MAPT 4610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.